BioSig Technologies Inc.

0.4900-0.0150-2.97%Vol 66.16K1Y Perf -24.64%
Oct 4th, 2023 16:00 DELAYED
BID0.4900 ASK0.5255
Open0.5050 Previous Close0.5050
Pre-Market- After-Market0.47
 - -  -0.02 -4.06%
Target Price
2.75 
Analyst Rating
Moderate Buy 2.00
Potential %
461.22 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
     25.74
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
17.06 
Earnings Rating
Neutral
Market Cap36.71M 
Earnings Date
13th Nov 2023
Alpha-0.01 Standard Deviation0.29
Beta1.34 

Today's Price Range

0.49000.5254

52W Range

0.25141.65

5 Year PE Ratio Range

-3.20-3.30

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
1.87%
1 Month
-14.49%
3 Months
-57.02%
6 Months
-55.05%
1 Year
-24.64%
3 Years
-90.34%
5 Years
-91.09%
10 Years
-

TickerPriceChg.Chg.%
BSGM0.4900-0.0150-2.97
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
0.40
1.20
0.22
0.48
-
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
81.10
-18 406.30
-18 239.00
-
-
RevenueValueIndustryS&P 500US Markets
151.00K
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q01 2023-0.10-0.12-20.00
Q03 2022-0.14-0.140.00
Q02 2022-0.17-0.1511.76
Q03 2020--0.38-
Q02 2020--0.72-
Q01 2020-0.25-0.46-84.00
Q03 2019--0.25-
Q02 2019--0.38-
Earnings Per EndEstimateRevision %Trend
6/2023 QR-0.080.00-
9/2023 QR-0.080.00-
12/2023 FY-0.42-425.00Negative
12/2024 FY-0.2431.43Positive
Next Report Date13th Nov 2023
Estimated EPS Next Report-0.08
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume66.16K
Shares Outstanding74.93K
Shares Float66.03M
Trades Count288
Dollar Volume33.27K
Avg. Volume377.45K
Avg. Weekly Volume124.64K
Avg. Monthly Volume259.71K
Avg. Quarterly Volume748.01K

BioSig Technologies Inc. (NASDAQ: BSGM) stock closed at 0.49 per share at the end of the most recent trading day (a -2.97% change compared to the prior day closing price) with a volume of 66.16K shares and market capitalization of 36.71M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 53 people. BioSig Technologies Inc. CEO is Kenneth L. Londoner.

The one-year performance of BioSig Technologies Inc. stock is -24.64%, while year-to-date (YTD) performance is 16.67%. BSGM stock has a five-year performance of -91.09%. Its 52-week range is between 0.2514 and 1.65, which gives BSGM stock a 52-week price range ratio of 17.06%

BioSig Technologies Inc. currently has a PE ratio of -0.70, a price-to-book (PB) ratio of 16.18, a price-to-sale (PS) ratio of 191.53, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -216.30%, a ROC of -267.99% and a ROE of -289.22%. The company’s profit margin is -%, its EBITDA margin is -18 239.00%, and its revenue ttm is $151.00 Thousand , which makes it $0.00 revenue per share.

Of the last four earnings reports from BioSig Technologies Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.08 for the next earnings report. BioSig Technologies Inc.’s next earnings report date is 13th Nov 2023.

The consensus rating of Wall Street analysts for BioSig Technologies Inc. is Moderate Buy (2), with a target price of $2.75, which is +461.22% compared to the current price. The earnings rating for BioSig Technologies Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioSig Technologies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioSig Technologies Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.08, ATR14 : 0.06, CCI20 : 0.54, Chaikin Money Flow : -0.15, MACD : -0.03, Money Flow Index : 74.33, ROC : 2.08, RSI : 43.20, STOCH (14,3) : 24.62, STOCH RSI : 0.29, UO : 26.88, Williams %R : -75.38), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioSig Technologies Inc. in the last 12-months were: Londoner Kenneth (Buy at a value of $32 750), LONDONER KENNETH L (Buy at a value of $7 040), Steven J. Buhaly (Buy at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

BioSig Technologies Inc.

BioSig Technologies Inc is a medical technology company. The firm is commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. Its first product, PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The company's subsidiary is seeking to develop a novel pharmaceutical called merimepodib to treat patients with COVID-19.

CEO: Kenneth L. Londoner

Telephone: +1 203 409-5444

Address: 54 Wilton Road, Westport 06880, CT, US

Number of employees: 53

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

55%45%

 

News

Stocktwits